Actions Panel
Metastatic Colorectal Cancer Workshop - Washington DC
Join a panel of expert faculty in this interactive half-day workshop discussing mCRC biomarkers and treatment options.
When and where
Date and time
Thursday, April 27 · 8:30am - 1pm EDT
Location
Milken Institute School of Public Health 950 New Hampshire Avenue Northwest #2 Washington, DC 20052
About this event
- 4 hours 30 minutes
- Mobile eTicket
Earn 4.5 hours of educational credit at a complimentary summit on mCRC biomarkers
Overview
The goal of this initiative is to provide guidance for the multidisciplinary CRC care team on how to develop practical biomarker testing protocols for mCRC and how this information supports personalized treatment decisions for improved patient outcomes.
Participants will actively engage in interactive small-group activities, including:
- A multidisciplinary molecular-based tumor board panel
- Breakout sessions delving into biomarker testing guidelines, challenges, and treatment selection
- Patient counseling and shared decision-making
Expert Faculty
- Antonia Sepulveda, MD, PhD - George Washington University School of Medicine and Health Sciences
- Wei Jiang, MD, PhD - Thomas Jefferson University
- Benjamin Swanson, MD, PhD - University of Nebraska
- Philip A. Philip, MD, PhD - Wayne State University
- Marcus Noel, MD - Medstar Georgetown University Hospital
- Benjamin Weinberg, MD - Medstar Georgetown University Hospital
- Frank dela Rama RN, MS, AOCNS - Sutter Health, Palo Alto Foundation
Agenda
- 8:20am: Doors open
- 8:30am: Workshop begins with Tumor Board (light breakfast provided)
- 10:00am: Breakout sessions: (1) Biomarker testing guidelines and challenges; (2) Linking biomarkers to mCRC Treatment Selection; (3) Patient Counseling
- 11:30am: Problem-Based Learning exercise- mCRC patient cases
- 12:30pm: Action planning and Summary Report Outs
- 1:00pm: Workshop concludes (boxed lunch grab-n-go provided)
Visit The France Foundation Registration page for additional information
This activity is provided by an educational grant from Pfizer.